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Besides being a useful tool in research, gene transfer has a high potential as treatment for a variety of genetic and acquired diseases. However,
in order to enable a gene to become a pharmaceutical, efficient and safe methods of delivery have to be developed. We recently found that cationic
amphipathic histidine-rich peptide antibiotics can efficiently deliver DNA into mammalian cells. Our lead compound, LAH4 (KKALLA-
LALHHLAHLALHLALALKKA), demonstrated in vitro transfection efficiencies comparable to those of commercially available reagents.
Synthesis and evaluation of LAH mutants provided evidence that the transfection efficiency depends on the number and positioning of histidine
residues in the peptide as well as on the pH at which the in-plane to transmembrane transition takes place. Moreover, recent results suggest that
binding of the DNA complexes to the plasma membrane is mediated by heparan sulfate proteoglycans and that anionic phospholipids may be
involved in the endosomal destabilization process. Finally, we also describe in this review the rationale that led to the development of LAH4 as a
DNA carrier as well as the biophysical methods that have allowed us to propose a model which could explain the way this peptide destabilizes the
endosomal bilayer.
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Nucleic acid delivery has an extremely high potential in a
wide variety of applications, including basic research, therapies
for genetic and acquired diseases and in vaccination. However,
DNA expression cassettes as well as other nucleic acid-based
drugs such as siRNAs and antisense oligonucleotides enter into
mammalian cells with low efficiencies. It is thus necessary to
develop techniques able to efficiently deliver these bioactive
compounds in order to enable full exploitation of their
therapeutic potential.
One delivery approach that has been developed exploits the
properties and tropisms of viruses. This is currently the most
widely used system for gene delivery, particularly in clinical
trials. All other approaches, collectively termed “non-viral gene
delivery systems” try to mimic the efficiency of viral vectors by
artificial means [1]. These approaches are essentially of two
sorts: the first one uses physical methods to deliver DNA into⁎ Corresponding author. Tel.: +33 1 69 47 10 28; fax: +33 1 60 77 86 98.
E-mail address: akich@genethon.fr (A. Kichler).
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doi:10.1016/j.bbamem.2006.02.005cells. Among these techniques we find for example electro-
poration [2] and hydrodynamic DNA injection [3]. These
approaches are more useful for in vivo applications than for in
vitro experiments. The second approach consists in using
structurally well-defined synthetic compounds, which are most
often cationic. A large variety of molecules have been used,
ranging from polypeptides such as polylysine [4], to synthetic
polymers [5] and cationic lipids [6]. These molecules share
several functions that are essential for transfection: besides
packaging the DNA, they also protect it from nucleases and
usually form positively charged particles which efficiently enter
the cell after binding proteoglycans on the outer face of the
membrane [7]. The carrier probably also facilitates the escape of
the DNA complexes from intracellular vacuolar compartments
into the cytosol.
Peptides are mostly used as auxiliary agents in combination
with other gene transfer systems, in particular cationic polymers
such as polylysine, providing either a cell targeting moiety [8], a
membrane destabilization activity [9] or a nuclear localisation
function [10]. A strategy that emerged in the mid-90s is the use
of multifunctional peptides. Peptides such as KALA [11],
Fig. 1. Helical wheel diagram for LAH4 (residues 3–23). The helical wheel
projections allow to visualize the distribution of hydrophobic and polar residues
with respect to the helical axis. The angle of the positively charged helix face
(histidine residues are in italic), at pH 5, for the LAH4 peptide is 100°.
Table 1
Sequence of the LAH1–LAH5 series
Peptide Sequence
LAH1 KKLALALALALHALALALALKKA
LAH2 KKLAHLALALALGLALAHLAKKA
LAH3 KKALALGLHLAHLALHLALALKKA
LAH4 KKALLALALHHLAHLALHLALALKKA
LAH5 KKALLALALHHLAHLAHHLALALKKA
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time bind DNA and destabilize membranes—two properties
that seem required for efficient gene transfer of dividing cells.
Interestingly, the two former peptides combine a positively
charged lysine or arginine stretch required for DNA binding and
an amphipathic membrane-destabilizing domain deriving from
the fusogenic peptides GALA [11] and JTS-1 [15]. These
transfecting peptides have a strong propensity for a α-helical
conformation that positions the lysines or arginines on one face
of the helix—thus, conferring amphiphilic properties.
In this review, we discuss the rationale that led to the
development of a new family of transfection agent and we
present a model that could explain how these peptides function.
2. Antimicrobial peptides
At present, more than 800 different antimicrobial peptides
have been described—the list is available at the Antimicrobial
Sequences Database (http://www.bbcm.units.it/~tossi/pag1.
htm). These peptides are produced in many tissues and cell
types of a variety of invertebrate, plant and animal species,
including humans [16–20]. They can be classified into several
groups on the basis of their origin, activity spectrum or
structure. However, since similar structural patterns are shared
by peptides from different organisms, a classification based on
amino acid composition and structure is the most useful [16]. 5
subgroups can be identified [21]: (i) anionic peptides, (ii) linear
cationic α-helical peptides, (iii) cationic peptides enriched for
specific amino acids, (iv) anionic and cationic peptides that
contain cysteine and form disulphide bonds, and (v) anionic and
cationic peptide fragments of larger proteins.
Notably, the linear cationic α-helical peptide subgroup is one
of the most important (containing almost 300 peptides; http://
www.bbcm.units.it/~tossi/pag1.htm) and these peptides have
the broadest spectrum of activity [22]. Typically, they have a
size ranging from 10 to 50 amino acid residues, present an
overall net positive charge due to excess arginine and lysine
residues and they contain a significant number of hydrophobicamino acids. In aqueous solutions, many of these peptides are
disordered, but in the presence of membranes, all or part of the
molecule adopts a α-helical conformation. Edmundson helical
wheel analysis shows that such a helix is often amphipathic with
the polar and hydrophobic amino acid side chains separated on
opposite faces of the helix (see for example Fig. 1). Proton-
decoupled 15N solid-state NMR [23], ATR-FTIR [24], fluores-
cence [25] and CD spectroscopy [26] on oriented samples
indicate that peptides such as magainins are oriented with their
helix long axis parallel to the membrane surface.
The precise mechanisms of how the peptides exert their
biological activity have not been completely elucidated. The
peptides are, however, likely to first be attracted by the negative
charges that exist on the outer face of Gram-negative
(lipopolysaccharide) and Gram-positive (lipoteichoic acid)
bacteria. The cytotoxic activity results then either from their
detergent-like properties or after the peptides have reached
intracellular targets [17,18,20].
3. Transfection activity of LAH peptides
3.1. LAH4
By taking into consideration the above-mentioned properties
of antibacterial peptides, in particular of the linear cationic
α-helical ones, we reasoned that most of them correspond
exactly to what could be the requirements for a “good” peptidic
DNA carrier, namely: the peptide should (i) be relatively short,
(ii) present cationic residues which allow electrostatic interac-
tions with DNA but with a limited positive charge density, (iii)
be soluble in aqueous solutions and, (iv) be able to interact with
and destabilize membranes.
We tested our hypothesis by evaluating the DNA condensing
and transfecting capacities of LAH4 and derivatives thereof.
LAH4 (Table 1) was initially designed as a model peptide to
study the membrane disturbing properties and interaction
contributions that determine the membrane topology of
α-helical amphipathic antibacterial peptides [17,27,28]. When
considering the primary sequence of the peptide, LAH4 is
characterized by the presence of two lysines at each end of the
peptide which, besides ensuring good solubility in aqueous
environments, allows for electrostatic interactions with DNA. In
addition to these cationic residues, LAH4 also contains
hydrophobic amino acids – alanines and leucines – as well as
4 histidines. The latter residues are of interest since they may
allow, thanks to the imidazole group, which has a pKa of about
6.0, the buffering, and subsequently disruption, of endosomal
vesicles [5,29].
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using circular dichroism [28]. At acidic pH, when the
histidines are charged, the peptide exhibits a mostly random
coil conformation. At neutral pH, a helical conformation is
induced with the helical content at pH 7.5 calculated to be
39%. As observed with other antimicrobial peptides such as
magainins, CD spectroscopy indicates that addition of
phospholipid membranes induces a helical conformation in
LAH4. The helix content of LAH4 at pH 5.5 increases
from 26% in the absence of membranes to 55% and 70%
in the presence of POPC or POPG liposomes, respectively
[28].
Finally, Edmundson helical wheel analysis shows that the
α-helix is amphipathic with the polar and hydrophobic amino
acid side chains separated on opposite faces of the helix (Fig. 1).
3.2. DNA condensing and transfecting properties of LAH4
Gel mobility shift assays showed that peptides encompassing
4 lysines and 1 to 5 histidines (LAH1–LAH5, Table 1) are able
to efficiently complex plasmid DNA [30]. The complete DNA
retardation was observed for all the peptides at a w/w peptide/
DNA ratio of 2.5/1. This corresponds to 0.59 peptide per bp or
expressed as +/− charge ratio to 1.5. Notably, no differences of
DNA complexation capacities were expected between the
LAH1–LAH5 peptides since all of them present 5 positive
charges at neutral pH.
Evaluation of the transfection efficiency was performed on
several cell lines by using an expression cassette encoding the
reporter gene luciferase. The results showed that the highest
activity was obtained with the peptides having at least 4
histidine residues [30]. The efficiency of LAH4 was also
compared to that of the branched PEI of 25 kDa and the
monocationic lipid DOTAP on four different cell lines. The
results indicate that the peptide has transfection capacities that
equal those of these two commercially available transfection
agents.
3.3. Synthesis and evaluation of LAH4 mutants
The synthesis of mutant peptides is interesting since in
addition to offering a better insight of what the requirements are
to obtain a high transfection efficiency, it can also lead to the
development of even more efficient compounds. A peptide of
26 amino acids, such as LAH4, has 2620 possible combinations
of only the standard L-amino acids and hence the possibilities of
peptide optimization are immense.Table 2
Histidine-rich peptides
Peptide Sequence
LAH4 KKALLALALHHLAHLALHLALALKKA
Histatin-5 DSHAKRHHGYKRKFHEKHHSHRGY
H4-LAK4 HHALLALALKKLAKLALKLALALHHA
a The indicated amount of peptide is the minimal amount required to retard migra
b We gave the value 1000 to the luciferase activity obtained with LAH4. Transfec
c Some of the DNA was retarded but not all.We synthesized a variety of peptides and tested their capacity
to complex DNA and transfect cells (Table 2 ; [30]). From their
evaluation, several conclusions can be drawn: (i) the ability of
peptides to complex DNA is not solely linked to the global
charge of the peptide suggesting that structural requirements
need to be fulfilled (histatin-5 for example did not complex well
DNA; Table 2), (ii) a comparison of results obtained with LAH4
and H4-LAK4 show that the histidine residues have to be
positioned in the core of the peptide, (iii) the position of the
histidine residues within the polar face is important but there is a
certain tolerance on the detailed location [30].
4. Mechanism
4.1. Cell binding
In order to promote cell entry of bioactive drugs such as
DNA, one can take advantage of two different strategies: the
first one consists in associating the drug with a carrier able to
favor cell penetration by a process referred to as non-specific
adsorptive endocytosis. The second one consists in coupling a
ligand that is recognized by a receptor expressed at the cell
surface to the carrier. This latter approach will not be detailed
here because it is beyond the scope of this review.
Most non-viral DNA carriers have their optimal transfection
activity when the particles present an overall net positive charge
(i.e., excess of cationic charges with respect to the DNA
phosphate). This may be explained by the fact that cationic
charges allow binding of the complexes to anionic lipids or
heparan sulfate proteoglycans (HSPGs) which may be present
on the cell surface. However, if LAH4 behaves similarly to
other tested peptides – like oligoarginines – then it is likely that
the initial attraction to the cell surface is mediated not by anionic
lipids but by proteoglycans [31]. In fact, it was shown for
polylysine-based [7] and lipid-based DNA complexes [32] that
the absence of HSPGs severely impairs the transfection
efficiency. Based on this observation, we performed binding
experiments on wild-type (CHO-K1) and mutant proteoglycan
deficient Chinese hamster ovary cells (A-745 cells; [33]) with a
fluorescently labelled LAH4 peptide. Preliminary data suggest
that the absence of HSPGs results in a significantly reduced
binding of the peptide to the cell surface (AK, unpublished
results). Further investigations are, however, needed in order to
fully characterize the binding partner(s) of LAH4/DNA
complexes. Our and others experiments seem to suggest that
anionic lipids do not have a significant role in the binding
affinity of cationic complexes to eukaryotic cells, howeverRetardation assay (μg peptide a) Transfection efficiency b
2.5 1000
>50 c 1<
1 20
tion of 1 μg of plasmid DNA during agarose gel electrophoresis.
tion experiments were performed on HepG2 cells.
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transfection of cationic complexes as we show below.
4.2. Cell entry
One approach which provides insights into the intracellular
trafficking of DNA complexes consists of using drugs which
interfere with cellular processes. A proton pump inhibitor such
as bafilomycin A1 for example, not only gives information
about the role of endosomal acidification during the transfection
process but can also indicate whether DNA particles enter the
cell through an endocytic pathway [34]. LAH4-mediated
transfection in the presence of bafilomycin A1 was significantly
lower as compared to non-treated cells [30]. Since histidines are
required to obtain maximal transfection with LAH peptides and
since the pK values of the four histidine imidazole groups of
LAH4, determined in the presence of dodecylphosphocholine
micelles, are 5.4, 5.8, 5.9 and 6.0 [27], the results suggest an
important role of histidine protonation. Moreover, the results
indicate that at least some of the complexes enter through
endocytosis. Whether the complexes enter through clathrin-
mediated endocytosis as it is the case for Vpr for example [35]
remains to be shown.
4.3. Endosomal escape
Solid-state NMR has proven to be an excellent means of
studying peptide–lipid interactions. Spectral features in such
studies are sensitive to the chemical environment, orientation
with respect to an external magnetic field and the motions of
membrane components that carry an NMR active nucleus.
Oriented membrane samples have been used extensively in this
laboratory to study peptides inserted into membrane mimicking
lipid bilayers. Specific 15N labelling of the LAH4 peptide and
subsequent incorporation into hydrated phospholipid bilayers
allows the 15N chemical shift anisotropy (CSA) to be
determined which, for an α-helical peptide, gives a direct
measure of the helix tilt angle [36]. LAH4 has been shown to
adopt an alignment parallel to the membrane surface at acidic
pH, whilst at neutral pH it is transmembrane [27,37]. The
midpoint of transition occurs at pH50=6.1.
Antimicrobial peptides induce a variety of effects on
biological membranes including causing the release of calcein
from dye loaded vesicles, inducing lipid flip-flop and can,
themselves, translocate from one side of the membrane to
another [38,39]. The insertion of a peptide into a transmem-
brane orientation has been shown to be sufficient to induce lipid
flip-flop [40] whilst the induction of anionic lipid flip-flop has
been proposed as an important factor in the release of cationic
complexes from endosomes [41]. Hence, the ability of LAH4
and derivatives to induce such effects may be crucial in
determining the efficiency of transfection depending on the cell
type under investigation.
To further probe the mechanism of LAH4 mediated DNA
transfection we have shown using wide-line 31P NMR of
hydrated peptide–lipid powder samples that both magainin and
LAH4 can induce large scale morphological changes inphospholipid bilayers at increasing concentrations [18,42]. A
powder pattern that is commonly obtained for hydrated
phospholipids bilayers is replaced by a sharp resonance
representing an oriented bilayer which, depending on the 31P
chemical shift position would correspond to a micellar, a
bicellar or a wormlike sheet phase [43,44]. This could provide a
mechanism for the disruption of the endosomal membrane as
LAH4 peptides are released from the cationic peptide/DNA
complex on acidification of the endosomal lumen.
Further details of the mechanism of membrane disruption
have been obtained from identifying the nature of the peptide–
lipid interactions. Many membrane active peptides are cationic
in nature and have been shown to interact with anionic lipids in
bacterial membranes. Such anionic lipids are usually only
present on the intracellular face of eukaryotic membranes
although they can also be found on the external surface when
cells become transformed [45]. The change in surface charge
caused by the binding of a cationic peptide to an anionic
membrane can also be measured using solid-state NMR
methods. The concept of the “molecular voltmeter” where the
quadrupolar splitting observed in wideline 2H spectra of
headgroup deuterated lipids has recently been extended to
include 31P and 14N MAS methods [46,47] which are based on
the known response of the chemical shift and quadrupolar
coupling respectively, to a change in surface charge. Both these
latter techniques are rather useful since they do not require
stable isotope labelling as the NMR active nuclei comprise
almost 100% of the natural isotope abundance, and under MAS
conditions, resonances from different lipid types can be
separated. Using this 31P MAS technique we have shown that
LAH4 does indeed interact preferentially with anionic lipids in
mixed anionic/zwitterionic membranes and this interaction is
enhanced at acidic pH when the four histidine residues become
positively charged [42].
To understand this interaction in further detail we have
incorporated chain deuterated lipids into mixed membranes
and observed the effect on the quadrupolar splittings
throughout the lipid acyl chain as a probe of the chain order.
Wideline 2H NMR of such systems provides information on
the dynamic structure of the lipid acyl chains [48] and can
identify membrane disruption or peptide binding to specific
membrane constituents [49]. We found that in a lipid bilayer
composed of phosphatidylcholine, phosphatidylserine and
cholesterol LAH4 caused a significant reduction of lipid acyl
chain order for deuterated phosphatidylserine at acidic pH but
not at neutral pH. By contrast, when deuterated phosphatidyl-
choline was used as a reporter at both acidic and neutral pHs
no such effect was observed [42]. These observations are
consistent with a model whereby LAH4 inserts into the
membrane and inserts preferentially in the vicinity of anionic
lipid head groups. The degree of membrane destabilization
was assessed for a number of LAH4 isomers and it was
discovered that this was related to the ability of the same
isomers to mediate transfection of a variety of both primary
and transformed cell lines [42]. These results indicate that
anionic lipids play an important role in the release mechanism
of the LAH4/DNA complex.
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On the basis of our results, we can propose the following
model for the way LAH4 acts (Fig. 2). LAH4/DNA
complexes that lead to the highest reporter gene expression
are those generated at a w/w peptide/DNA transfection ratio
of 6/1 [30]. Translated in a molar ratio, it gives 1.42 LAH4/bp
and expressed as +/− charge ratio, it gives 3.6. This ratio is,Fig. 2. Schematic figure showing the key steps of LAH4 mediated DNA transfecti
histidines are in bold) to plasmid DNA at a 1.4 LAH4/bp ratio generates positively
complexed peptide. (2) Particles and peptides interact with the cell membrane, pref
complexes as well as free peptide enter the cell through endocytosis. At neutral pH, L
During acidification of the endosome, histidine residues become protonated and LA
followed by the release of DNA (+LAH4?) into the cytosol.however, likely to be overestimated since not all the peptides
bind to DNA (unpublished results). With an overall net
positive charge, one can hypothesize that the complexes bind
to the cell membrane via non-specific electrostatic interac-
tions. The binding sites on the cell surface are probably
sulfated proteoglycans, as suggested by experiments done
with HSPGs deficient cells. After binding, non-specific
endocytosis allows for cell entry of DNA particles as wellon of eukaryotic cells. (1) Addition of LAH4 (lysine residues are in green and
charged DNA complexes (green sphere) but leaves also a proportion of non-
erentially with proteoglycans, via non-specific ionic interactions. (3) The DNA
AH4 is either associated with DNA or it adopts a transmembrane orientation. (4)
H4 adopts an in-plane alignment. (5) Membrane destabilization occurs and it is
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when the pH is still above 6, LAH4 adopts a transmembrane
orientation. During acidification of the endosome, the
histidine residues become protonated and LAH4 presents an
overall net charge of +9 instead of +5. This event probably
frees a significant amount of LAH4 from DNA. In the acidic
environment of late endosomes, LAH4 adopts an in-plane
orientation, interacts with negatively charged lipids and, if
the concentration of peptide is high enough, this is followed
by a membrane destabilization that allows DNA and/or
DNA/LAH4 to enter the cytosol. Exactly how membrane
permeabilisation occurs remains to be determined. Possible
mechanisms include detergent-like [17] or flip-flop [41] induced
destabilization.
5. Conclusion
We developed a biotechnologically feasible approach for
gene delivery using synthetic cationic amphipathic peptides
containing a variable number of histidine residues. Gene
transfer to different cell lines in vitro was achieved with an
efficiency comparable to commercially available reagents. It
should, however, be kept in mind that the gap between viral
and non-viral vectors is still significant. Indeed, not only do
recombinant viruses need fewer gene copy numbers to achieve
the same efficiency as non-viral vectors but they are also
capable of efficiently transducing various primary cells such as
dendritic cells or stem cells which have a therapeutical
potential. Thus, current use of synthetic carriers in clinical
trials is hampered by their low efficiency as well as by their
cytotoxicity—induced either by their low biodegradability or
due to the high concentration of complexes required for gene
transfer. Taken together, the existing transfection agents are
useful tools for fundamental research but in order for them to
become also useful in clinical trials, it will be necessary to
precisely understand the transfection process as we are
beginning to do with LAH4. This in turn will allow the
development of approaches able to overcome each identified
limiting step.
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